Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 4/20 | 1.00 |
| ▸ | HKDC1 | Q2TB90 | 3/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | TNNI3 | P19429 | 2/20 | 1.00 |
| ▸ | TNNT2 | P45379 | 2/20 | 1.00 |
| ▸ | TNNC1 | P63316 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 1.00 |
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | GLA | P06280 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sennoside B SCHEMBL19004132 | 1.00 | USP2 (1.00) | USP2HKDC1L3MBTL1TDP1KDM4E | |
| Sennoside B SCHEMBL14478776 | 1.00 | USP2 (1.00) | USP2HKDC1L3MBTL1TDP1KDM4E | |
| Sennoside B SCHEMBL15216902 | 1.00 | USP2 (1.00) | USP2HKDC1L3MBTL1TDP1KDM4E | |
| Sennoside B SCHEMBL19235654 | 1.00 | USP2 (1.00) | USP2HKDC1L3MBTL1TDP1KDM4E | |
| Sennoside B SCHEMBL17430774 | 1.00 | USP2 (1.00) | USP2HKDC1L3MBTL1TDP1KDM4E | |
| Sennoside B SCHEMBL19004127 | 1.00 | USP2 (1.00) | USP2HKDC1L3MBTL1TDP1KDM4E | |
| Sennoside B SCHEMBL23685626 | 1.00 | USP2 (1.00) | USP2HKDC1L3MBTL1TDP1KDM4E | |
| Sennoside B SCHEMBL17131971 | 1.00 | USP2 (1.00) | USP2HKDC1L3MBTL1TDP1KDM4E | |
| Sennoside A,B SCHEMBL20822082 | 1.00 | USP2 (1.00) | USP2HKDC1L3MBTL1TDP1KDM4E | |
| Sennoside B SCHEMBL14353400 | 1.00 | USP2 (1.00) | USP2HKDC1L3MBTL1TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 519 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021153-A1 | TRADITIONAL CHINESE MEDICINE FORMULATION FOR PREVENTING AND TREATING CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-C) | CENTRE FOR CHINESE HERBAL MEDICINE DRUG DEVELOPMENT LTD (CN) | 2026-01-22 | — | — | US | claimed |
| CN-119925401-A | Application of sennoside B in preparation of medicines for preventing and treating renal fibrosis caused by urinary tract obstruction | 海南大学 | 2025-05-06 | — | — | CN | claimed |
| CN-113421620-B | Based on UPLC-Q-TOF/MSEMethod for carrying out fuzzy recognition on bioactive components with different effects of traditional Chinese medicine by BP neural network correlation analysis of integration effect | 陕西中医药大学 | 2025-04-29 | — | — | CN | claimed |
| CN-118844546-B | Feed additive containing alfalfa extract and preparation method and application thereof | 北京都润科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| US-20250099508-A1 | SYSTEMS, CELL LINES AND METHODS OF PRODUCING AND USING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-03-27 | — | — | US | claimed |
| CN-118032965-B | Method for measuring content of multiple components in senna leaf formula granules or standard decoction freeze-dried powder | 山东宏济堂制药集团股份有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119000603-A | Comprehensive evaluation method and system for multiple key quality attribute indexes of tanggutta-percha rhubarb medicinal material | 中国科学院西北高原生物研究所 | 2024-11-22 | — | — | CN | claimed |
| EP-4460314-A2 | SYSTEMS, CELL LINES AND METHODS OF PRODUCING AND USING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-11-13 | — | — | EP | claimed |
| CN-118844546-A | Feed additive containing alfalfa extract and preparation method and application thereof | 北京都润科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118032965-A | Method for measuring content of multiple components in senna leaf formula granules or standard decoction freeze-dried powder | 山东宏济堂制药集团股份有限公司 | 2024-05-14 | — | — | CN | claimed |
| WO-2008027442-A2 | ABUSE DETERRENT ORAL PHARMACEUTICAL FORMULATIONS OF OPIOID AGONISTS AND METHOD OF USE | THERAQUEST BIOSCIENCES, LLC (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008021394-A2 | PHARMACEUTICAL FORMULATIONS OF CANNABINOIDS AND METHOD OF USE | THERAQUEST BIOSCIENCES, LLC (US) | 2008-02-21 | — | — | WO | claimed |
| US-20070104803-A1 | Chinese herbal composition for treating diseases | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2007-05-10 | — | — | US | claimed |
| CN-1810265-A | Total sennoside extract for treating constipation and its extraction process | NANJING HAILING CHINESE MEDICI (CN) | 2006-08-02 | — | — | CN | claimed |
| EP-0682665-A4 | ANTHRAQUINONE AND ANTHRACENE DERIVATIVES AS INHIBITORS OF THE CELL-ADHESION MOLECULES OF THE IMMUNE SYSTEM. | GLYCOMED INC (US) | 1996-01-10 | — | — | EP | claimed |
| EP-0682665-A1 | ANTHRAQUINONE AND ANTHRACENE DERIVATIVES AS INHIBITORS OF THE CELL-ADHESION MOLECULES OF THE IMMUNE SYSTEM | GLYCOMED INCORPORATED (US) | 1995-11-22 | — | — | EP | claimed |
| US-5412123-A | Anthraquinone and anthracene derivatives as inhibitors of the cell-adhesion molecules of the immune system | GLYCOMED INCORPORATED (US) | 1995-05-02 | — | — | US | claimed |
| WO-1994018189-A1 | ANTHRAQUINONE AND ANTHRACENE DERIVATIVES AS INHIBITORS OF THE CELL-ADHESION MOLECULES OF THE IMMUNE SYSTEM | GLYCOMED INCORPORATED (US) | 1994-08-18 | — | — | WO | claimed |
| US-5208151-A | Process for the preparation of derivatives of maltooligosaccharides | NIHON SHOKUHIN KAKO CO., LTD. (JP) | 1993-05-04 | — | — | US | claimed |
| US-4402944-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1983-09-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250099508-A1 | SYSTEMS, CELL LINES AND METHODS OF PRODUCING AND USING THE SAME | DCX, SLC10A2, CHAT | USP2 2040/4885HKDC1 3559/4885L3MBTL1 1262/4885 |
| US-20260021153-A1 | TRADITIONAL CHINESE MEDICINE FORMULATION FOR PREVENTING AND TREATING CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-C) | VIP, RDX, SI | USP2 1567/4885HKDC1 2615/4885L3MBTL1 4657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.